PMID- 38392838 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20240227 IS - 2076-0817 (Print) IS - 2076-0817 (Electronic) IS - 2076-0817 (Linking) VI - 13 IP - 2 DP - 2024 Jan 24 TI - p16 Expression in Laryngeal Squamous Cell Carcinoma: A Surrogate or Independent Prognostic Marker? LID - 10.3390/pathogens13020100 [doi] LID - 100 AB - Laryngeal squamous cell carcinoma (LSCC) is a common malignancy that, despite scientific advancements, has not seen an improvement in its prognosis in the last decades. Few promising predictive markers have been found and none are relevant in clinical practice. p16(ink4a), an oncosuppressor protein involved in cell cycle arrest, with a prognostic impact on other cancers, has been widely used in the head and neck region as a surrogate marker of HPV infection. Published papers and recent meta-analyses seem to minimize the biological role of HPV in the context of LSCC's cancerogenesis, and to disprove the reliability of p16(ink4a) as a surrogate prognostic marker in this context, while still highlighting its potential role as an independent predictor of survival. Unfortunately, the available literature, in particular during the last two decades, is often not focused on its potential role as an independent biomarker and few relevant data are found in papers mainly focused on HPV. The available data suggest that future research should focus specifically on p16(ink4a), taking into account both its potential inactivation and overexpression, different patterns of staining, and immunohistochemistry cutoffs, and should focus not on its potential role as a surrogate marker but on its independent role as a predictor of survival. FAU - Gallus, Roberto AU - Gallus R AUID- ORCID: 0000-0003-3343-2806 AD - Otolaryngology, Mater Olbia Hospital, 07026 Olbia, Italy. FAU - Rizzo, Davide AU - Rizzo D AUID- ORCID: 0000-0003-1830-3731 AD - U.O.C. Otorinolaringoiatria, Azienda Ospedaliero Universitaria di Sassari, Viale San Pietro, 43, 07100 Sassari, Italy. AD - Otolaryngology Division, Department of Medicine, Surgery and Pharmacology, University of Sassari, Viale San Pietro, 43, 07100 Sassari, Italy. FAU - Rossi, Giorgia AU - Rossi G AD - Unit of Otorhinolaryngology and Head-Neck Surgery, "A. Gemelli" Hospital Foundation IRCCS, 00168 Rome, Italy. FAU - Mureddu, Luca AU - Mureddu L AUID- ORCID: 0000-0002-2598-198X AD - U.O.C. Otorinolaringoiatria, Azienda Ospedaliero Universitaria di Sassari, Viale San Pietro, 43, 07100 Sassari, Italy. FAU - Galli, Jacopo AU - Galli J AD - Unit of Otorhinolaryngology and Head-Neck Surgery, "A. Gemelli" Hospital Foundation IRCCS, 00168 Rome, Italy. AD - Department of Head-Neck and Sensory Organs, Catholic University of Sacred Heart, 00168 Rome, Italy. FAU - Artuso, Alberto AU - Artuso A AD - Otolaryngology, Mater Olbia Hospital, 07026 Olbia, Italy. FAU - Bussu, Francesco AU - Bussu F AUID- ORCID: 0000-0001-6261-2772 AD - U.O.C. Otorinolaringoiatria, Azienda Ospedaliero Universitaria di Sassari, Viale San Pietro, 43, 07100 Sassari, Italy. AD - Otolaryngology Division, Department of Medicine, Surgery and Pharmacology, University of Sassari, Viale San Pietro, 43, 07100 Sassari, Italy. LA - eng PT - Journal Article PT - Review DEP - 20240124 PL - Switzerland TA - Pathogens JT - Pathogens (Basel, Switzerland) JID - 101596317 PMC - PMC10892421 OTO - NOTNLM OT - HPV OT - LSCC OT - p16ink4a inactivation OT - p16ink4a overexpression OT - prognostic marker COIS- The authors declare no conflicts of interest. EDAT- 2024/02/23 12:43 MHDA- 2024/02/23 12:44 PMCR- 2024/01/24 CRDT- 2024/02/23 10:25 PHST- 2024/01/07 00:00 [received] PHST- 2024/01/21 00:00 [revised] PHST- 2024/01/22 00:00 [accepted] PHST- 2024/02/23 12:44 [medline] PHST- 2024/02/23 12:43 [pubmed] PHST- 2024/02/23 10:25 [entrez] PHST- 2024/01/24 00:00 [pmc-release] AID - pathogens13020100 [pii] AID - pathogens-13-00100 [pii] AID - 10.3390/pathogens13020100 [doi] PST - epublish SO - Pathogens. 2024 Jan 24;13(2):100. doi: 10.3390/pathogens13020100.